Cargando…
Genetic and pharmacological validation of TAK1 inhibition in macrophages as a therapeutic strategy to effectively inhibit TNF secretion
Immune challenge of invading macrophages at sites of infection is associated with release of TNF, which triggers a local cytokine storm as part of the normal inflammatory response. Whereas this response maybe beneficial in fighting off infections, similar responses triggered in autoimmune diseases c...
Autores principales: | Scarneo, Scott A., Mansourati, Antoine, Eibschutz, Liesl S., Totzke, Juliane, Roques, Jose R., Loiselle, David, Carlson, David, Hughes, Philip, Haystead, Timothy A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6242965/ https://www.ncbi.nlm.nih.gov/pubmed/30451876 http://dx.doi.org/10.1038/s41598-018-35189-7 |
Ejemplares similares
-
Pharmacological inhibition of TAK1, with the selective inhibitor takinib, alleviates clinical manifestation of arthritis in CIA mice
por: Scarneo, Scott A., et al.
Publicado: (2019) -
TAK1 regulates the tumor microenvironment through inflammatory, angiogenetic and apoptotic signaling cascades
por: Scarneo, Scott A., et al.
Publicado: (2020) -
TAK1: a potent tumour necrosis factor inhibitor for the treatment of inflammatory diseases
por: Totzke, Juliane, et al.
Publicado: (2020) -
Pharmacological inhibition of TAK1 prevents and induces regression of experimental organ fibrosis
por: Bale, Swarna, et al.
Publicado: (2023) -
Delineation of the distinct inflammatory signaling roles of TAK1 and JAK1/3 in the CIA model of rheumatoid arthritis
por: Freeze, Robert, et al.
Publicado: (2023)